Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Kidney International
Published October 20, 2026
The Chronic Renal Insufficiency Cohort (CRIC) study measured hepcidin, cardiovascular, kidney and...
October 21, 2026
Medspoke
Medspoke
Kidney International
Published October 20, 2026
00:00
--:--
Safety outcomes of semaglutide by chronic kidney disease severity in the FLOW trial.
October 21, 2026
Share
Safety outcomes of semaglutide by chronic kidney disease severity in the FLOW trial.
https://www.medspoke.co/channel_journal?id=797&tap_id=16003
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of Clinical Oncology
Published October 20, 2026
Association of Circulating Eosinophils With Systemic Immune Activation and Reduced Recurrence in ...
October 21, 2026
Why are you reporting this TALK?
